Navigation Links
ARMO BioSciences to Present at the Leerink Partners Global Healthcare Conference
Date:2/3/2016

REDWOOD CITY, Calif., Feb. 3, 2016 /PRNewswire/ -- ARMO BioSciences, Inc., a clinical stage developer of immuno-oncology therapeutics, today announced that the company's President and Chief Executive Officer Peter Van Vlasselaer, Ph.D. will present at the Leerink Partners 5th Annual Global Healthcare Conference on Thursday, February 11, 2016 at 1:25 pm Eastern Time (10:25 am Pacific Time).

Event: Leerink Partners 5th Annual Global Healthcare Conference 
Date: Thursday, February 11, 2016 
Time: 1:25 - 1:45 pm Eastern Time (10:25 – 10:45 am Pacific Time) 
Location: Waldorf Astoria Hotel, New York, N.Y. 
Webcast:  A live audio webcast of the presentation can be accessed from the company's website at http://www.armobio.com/news-events.php.  A replay will be available for 14 days following the presentation.

About ARMO BioSciences: 
Founded in 2012, ARMO BioSciences is a clinical-stage company developing immunotherapies focused on multiple difficult-to-treat oncology indications. The company's lead immunotherapy AM0010, a PEGylated form of recombinant human IL-10, primes the tumor micro-environment for immune-mediated therapies and has demonstrated durable clinical responses in several types of cancer, as both a single agent and in combination with standard-of-care chemotherapy or anti-Programmed Cell Death Protein (anti-PD-1) monoclonal antibodies. ARMO plans to initiate the first of several registration-enabling phase 2/3 studies for AM0010 in solid tumors. The company also has a robust pipeline of therapeutic cytokines and an anti-PD-1 checkpoint inhibitor.

For more information, please visit www.armobio.com

Contact: 
ARMO BioSciences 
Scott Ogg, Ph.D.  
Vice President Corporate Development and Operations 
+1-650-779-5075 
contact@armobio.com


'/>"/>
SOURCE ARMO BioSciences, Inc.
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Swift Biosciences and SeraCare Partner on Circulating Tumor DNA Standards for NGS-Based Oncology Assays
2. Kindred Biosciences Releases Positive Results of Pilot Field Study of KIND-010 for the Management of Weight in Cats
3. Dramatic Turn in Story of Invalidated 813 Patent For Treating Binge Eating Disorder as Owner Lucerne Biosciences Provides Patent Board Profile of itself and its High 40-75% Misrepresentation Rate
4. Pressure BioSciences Exceeds $5 Million PIPE Goal and Opens $1.25 Million Over-Subscription Amount
5. Sangamo BioSciences Highlights 2016 Catalysts at the 34th Annual J.P. Morgan Healthcare Conference
6. Kindred Biosciences Submits KIND-012 New Animal Drug Application Technical Section for Chemistry, Manufacturing, and Controls to FDA
7. Pressure BioSciences Eliminates All Remaining Variable Rate (Floorless) Convertible Notes
8. Profectus BioSciences Receives $4.6 Million DOD Grant to Develop Vaccine for Western, Eastern, and Venezuelan Equine Encephalitis Viruses
9. SRI Biosciences and Stanford Cancer Institute Launch Drug Discovery Program
10. Prosetta Biosciences, Inc. Announces Closing Of Private Placement
11. Kindred Biosciences Announces Positive Results from Pivotal Study of KIND-012 for Pyrexia in Horses, and Provides Other Product Updates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2020)... ... ... Bleep LLC, maker of the DreamPort mask-less CPAP solution, announced today that ... , “In my line of work, a good night of sleep is critical to ... a Bleeping no brainer for me,” said Jensen. “From the moment I started using ...
(Date:8/27/2020)... ... ... The GHT Companies , a leading developer and distributor of nutraceutical ... with a press conference at its manufacturing facility in Vista. Here are ... an overall donation result exceeding $30,000 to Feeding San Diego, Who: Jim Rex, ...
(Date:8/26/2020)... ... August 26, 2020 , ... ... Eurofins BioPharma Services, Laboratory Testing division, expands its technology footprint with the ... Flow Cytometry platforms available. With industry-leading biomarker solutions, complemented with traditional ligand-binding ...
Breaking Medicine Technology:
(Date:8/31/2020)... ... August 31, 2020 , ... Just found out your dear friend has cancer? , ... your friend or family member shares their diagnosis. Once the shock wears off, the questions ... wrong thing? What are the best ways to help? Words are failing me. I’m scared. ...
(Date:8/31/2020)... , ... August 31, 2020 , ... ... innovative higher-learning opportunities through high-quality, career-relevant, and affordable online education – is proud ... . , Among the first of its kind in the nation, the ...
(Date:8/31/2020)... ... August 31, 2020 , ... In an effort to ... is donating 10 percent of each hotel room booked with a special new ... Chicagoland & Northwest Indiana (RMHC-CNI) , effective immediately. Donations will be applied to ...
(Date:8/28/2020)... ... August 28, 2020 , ... Ernst & ... was named an Entrepreneur Of The Year® 2020 Florida Award finalist. Now in ... whose ambitions deliver innovation, growth and prosperity as they build and sustain successful ...
(Date:8/28/2020)... ... ... Integrated Viral Protection (IVP Air) today announced that the True North ... Biodefense Indoor Air Protection System that is the first system designed and proven to ... with the filtration system on September 8th. , The IVP Air S1 model ...
Breaking Medicine News(10 mins):